We are pleased and excited to announce the reintroduction of phycox to our hospital inventory as an aid in the fight against canine arthritis. The original manufacturer, Pharma Chemie, has been able to reintroduce it because the previous companies (DVM and Teva animal health) had their license to market phycox expire. The original difficulties arose when manufacturing shortcomings caused DVM to decide to remove all of its product lines from distribution. Although there were never any specific problems with the quality or effectiveness of phycox, DVM decided to take a broad stance to assure product quality. Pharma Chemie, the holder of the original patent on phycox then decided to remarket it under its own label. The ONLY difference will be that new bottles will not have the "JS" on the label. Otherwise, the product is identical. We apologize for the incovenience this may have caused and do not anticipate any further problems with what we consider to be an excellent tool in helping us to keep our canine patients more comfortable.